> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-133/
- Published: 2017-05-07T12:00:00.000Z
- Updated: 2026-09-14T22:22:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138584

[**Pediatric Panels to Review Duchenne Trial Protocol**](https://www.fdaweb.com/pediatric-panels-to-review-duchenne-trial-protocol/) 05/02/2017  
*Federal Register* notice: FDA announces a 5/18 joint Pediatric Advisory Committee and Pediatric Ethics Subcommittee meeting to discuss a referral by an Institutional Review Board of a clinical investigation that involves children with Duchenne muscular dystrophy.

[**FDA Seeks Comments on GLP Recordkeeping**](https://www.fdaweb.com/fda-seeks-comments-on-glp-recordkeeping/) 05/02/2017  
*Federal Register* notice: FDA seeks comments on an information collection extension for “Good Laboratory Practice Regulations for Nonclinical Studies — 21 CFR Part 58 OMB Control Number 0910–0119.”

[**Comments Sought on Patent Term Restoration Petitions**](https://www.fdaweb.com/comments-sought-on-patent-term-restoration-petitions/) 05/02/2017  
*Federal Register* notice: FDA seeks comments on an information collection extension on “Patent Term Restoration, Due Diligence Petitions, Filing, Format, and Content of Petitions — 21 CFR Part 60 — OMB Control Number 0910–0233.” 

[**Conference for Small Business Industry Assistance**](https://www.fdaweb.com/conference-for-small-business-industry-assistance/) 05/03/2017  
*Federal Register* notice: CDER and CDRH announce a two-day (5/9-10) public conference entitled “FDA Small Business and Industry Assistance Regulatory Education for Industry (REdI) Spring Conference.”

[**Workshop on Sentinel Queries**](https://www.fdaweb.com/workshop-on-sentinel-queries/) 05/03/2017  
*Federal Register* notice: FDA announces a 7/10 public workshop entitled “Sentinel Training at FDA.”

[**Marathon Granted Priority Review Voucher** ](https://www.fdaweb.com/marathon-granted-priority-review-voucher/)05/03/2017  
*Federal Register* notice: FDA issues a priority review voucher to Marathon Pharmaceuticals for its recently approved Emflaza (deflazacort) tablets and oral suspension for treating patients age five and older with Duchenne muscular dystrophy.

[**Comments Sought on Ampicillin Pediatric Data Report**](https://www.fdaweb.com/comments-sought-on-ampicillin-pediatric-data-report/) 05/03/2017  
*Federal Register* notice: FDA seeks comments on a report evaluating pediatric studies of ampicillin.

[**Comments Sought on New ID Form for FOI Requests**](https://www.fdaweb.com/comments-sought-on-new-id-form-for-foi-requests/) 05/04/2017  
*Federal Register* notice: FDA seeks comments on a new information collection on “Certification of Identity for Freedom of Information Act (FOIA) and Privacy Act Requests — OMB Control Number 0910.”

[**FDA Co-hosting Workshop on Device Cybersecurity**](https://www.fdaweb.com/fda-co-hosting-workshop-on-device-cybersecurity/) 05/04/2017  
*Federal Register* notice: FDA, the National Science Foundation and Department of Homeland Security, Science and Technology announce a public workshop entitled “Cybersecurity of Medical Devices: A Regulatory Science Gap Analysis.” 

[**Comments Sought on Extending Citizen Petition Guidance**](https://www.fdaweb.com/comments-sought-on-extending-citizen-petition-guidance/) 05/04/2017  
*Federal Register* notice: FDA seeks comments on an information collection extension for “Guidance for Industry on Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act.”